Natural Product: NPC305223

Natural Product IDNPC305223
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
1-O-(11'z-Octadecenyl)-Sn-Glycero-3-Phosphocholine
IUPAC Name [(2R)-2-hydroxy-3-[(Z)-octadec-11-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL480671
PubChem CID 21672239
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000256] Glycerophospholipids
        • [CHEMONTID:0002213] Glycerophosphocholines
          • [CHEMONTID:0001414] Monoalkylglycerophosphocholines

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey HEEMBWYZIJABCR-ZXAYODBVSA-N
Standard InCHI InChI=1S/C26H54NO6P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-22-31-24-26(28)25-33-34(29,30)32-23-21-27(2,3)4/h10-11,26,28H,5-9,12-25H2,1-4H3/b11-10-/t26-/m1/s1
SMILES CCCCCC/C=CCCCCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   507.37 Volume:   539.181
?
Van der Waals volume.
Dense:   0.941 LogP:   1.741
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   2.144
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -0.814
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   25.0 Rigid Bonds:   2.0
TPSA:   88.05
?
Topological Polar Surface Area.
H-Bond Acceptor:   7.0
H-Bond Donor:   1.0 Rings:   0.0
Heavy Atoms:   8.0

MedChem Properties

QED Drug-Likeness Score:   0.075 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   3.913 Fsp3:   0.923
MCE-18:   7.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.413 Fluc inhibitor:   0.0
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.004
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.0
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.137 Promiscuous compounds:   0.256

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.443 MDCK Permeability:   -4.931
Pgp-inhibitor:   0.081 Pgp-substrate:   0.0
PAMPA:   0.0
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.496
20% Bioavailability (F20%):   0.156 30% Bioavailability (F30%):   0.999
50% Bioavailability (F50%):   0.995

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   0.912
Plasma Protein Binding (PPB):   98.014% Volume Distribution (VD):   -0.236
Fu: 1.168%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.378
BSEP inhibitor:   1.0

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   1.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.006 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.281 CYP2D6-substrate:   0.651
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   1.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.995
HLM stability:   0.003
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  5.016 Half-life (T1/2):  0.801

ADMET: Toxicity

hERG Blockers:  0.334 hERG Blockers (10um):  0.565
Human Hepatotoxicity (H-HT):  0.856 Drug-induced Liver Injury (DILI):  0.0
AMES Toxicity:  0.022 Rat Oral Acute Toxicity:  0.408
Maximum Recommended Daily Dose:  0.978 Skin Sensitization:  1.0
Carcinogencity:  0.444 Eye Corrosion:  1.0
Eye Irritation:  0.998 Respiratory Toxicity:  0.986
Drug-induced Neurotoxicity:  0.025 Ototoxicity:  0.005
Hematotoxicity:  0.003 Drug-induced Nephrotoxicity:  0.999
Genotoxicity:  0.01 RPMI-8226 Immunitoxicity:  0.024
A549 Cytotoxicity:  0.0 Hek293 Cytotoxicity:  0.025
BCF:   0.876
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   4.362
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   6.094
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   3.013
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO85 Spirastrella abata Species Spirastrellidae Eukaryota n.a. n.a. n.a. PMID[10579872]
NPO85 Spirastrella abata Species Spirastrellidae Eukaryota n.a. n.a. n.a. PMID[11325244]
NPO85 Spirastrella abata Species Spirastrellidae Eukaryota n.a. n.a. n.a. PMID[12088447]
NPO85 Spirastrella abata Species Spirastrellidae Eukaryota n.a. n.a. n.a. PMID[22182501]
NPO85 Spirastrella abata Species Spirastrellidae Eukaryota n.a. n.a. n.a. Database[COCONUT]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2 Others Unspecified n.a. IC50 = 125.0 ug.mL-1 PMID[26046820]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC305223 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9167 High Similarity NPC127145
0.9167 High Similarity NPC475930
0.8696 High Similarity NPC328786
0.8696 High Similarity NPC201338
0.84 Intermediate Similarity NPC137620
0.84 Intermediate Similarity NPC474675
0.7451 Intermediate Similarity NPC238646
0.7143 Intermediate Similarity NPC474674
0.6909 Remote Similarity NPC178758
0.6909 Remote Similarity NPC192326
0.6909 Remote Similarity NPC322769
0.6071 Remote Similarity NPC474627
0.6042 Remote Similarity NPC478931
0.5818 Remote Similarity NPC170963
0.5818 Remote Similarity NPC324165
0.5818 Remote Similarity NPC114640
0.5818 Remote Similarity NPC126366
0.5818 Remote Similarity NPC608333
0.5417 Remote Similarity NPC63804
0.5417 Remote Similarity NPC482659
0.5306 Remote Similarity NPC473872
0.5303 Remote Similarity NPC325936
0.5161 Remote Similarity NPC474702
0.5152 Remote Similarity NPC82799

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC305223 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.6042 Remote Similarity NPD4840 Phase 4
0.5636 Remote Similarity NPD6950 Phase 2
0.5614 Remote Similarity NPD7347 Clinical (unspecified phase)
0.5179 Remote Similarity NPD6949 Clinical (unspecified phase)

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data